| Schedule of Equity-Classified Warrants |
The following table presents a summary of the activity for the Company’s equity-classified warrants during the three months ended March 31, 2026: | | | | Weighted Average Exercise Price | | Weighted Average Remaining Contractual Life (Years) | Total outstanding, December 31, 2025 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Total outstanding, March 31, 2026 | | | | | | | | Total exercisable, March 31, 2026 | | | | | | | |
The following table presents a summary of the activity for the Company’s equity-classified warrants during the three months ended March 31, 2025: | | | | Weighted Average Exercise Price | | Weighted Average Remaining Contractual Life (Years) | Total outstanding, December 31, 2024(1) | | | | | | | | | | | | | | | | | | (96,300) | | | | | | | | | | | | | | | | | | | | | | Total outstanding, March 31, 2025 | | | | | | | | Total exercisable, March 31, 2025 | | | | | | | |
(1) | Weighted average remaining contractual life at December 31, 2024 excludes 96,300 Pre-Funded Warrants issued September 2024 that do not have a contractual expiration date, for which 0 warrants remain outstanding and exercisable at March 31, 2025. |
|